These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7694815)

  • 1. Cytokeratin 19 fragments: a new marker for non-small-cell lung cancer.
    Stieber P; Bodenmüller H; Banauch D; Hasholzner U; Dessauer A; Ofenloch-Hähnle B; Jaworek D; Fateh-Moghadam A
    Clin Biochem; 1993 Aug; 26(4):301-4. PubMed ID: 7694815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYFRA 21-1 enzyme-linked immunosorbent assay. Evaluation as a tumor marker in non-small cell lung cancer.
    Lai RS; Hsu HK; Lu JY; Ger LP; Lai NS
    Chest; 1996 Apr; 109(4):995-1000. PubMed ID: 8635383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer.
    Pujol JL; Grenier J; Daurès JP; Daver A; Pujol H; Michel FB
    Cancer Res; 1993 Jan; 53(1):61-6. PubMed ID: 7677981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYFRA 21-1, a sensitive and specific new tumour marker for squamous cell lung cancer. Report of the first European multicentre evaluation. CYFRA 21-1 Multicentre Study Group.
    Rastel D; Ramaioli A; Cornillie F; Thirion B
    Eur J Cancer; 1994; 30A(5):601-6. PubMed ID: 7521651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical usefulness of CYFRA assay in diagnosing lung cancer: measurement of serum cytokeratin fragment.
    Sugama Y; Kitamura S; Kawai T; Ohkubo A; Hasegawa S; Kuriyama T; Kato H; Fukuoka M; Ohkawa J
    Jpn J Cancer Res; 1994 Nov; 85(11):1178-84. PubMed ID: 7530241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High levels of cytokeratin 19 fragments but no evidence of cytokeratins 1, 2, 10/11, 14 or filaggrin in the serum of squamous cell lung carcinoma patients.
    Miédougé M; Devys A; Simon M; Rouzaud P; Salama G; Reyre J; Pujazon M; Carles P; Serre G
    Tumour Biol; 2001; 22(1):19-26. PubMed ID: 11054023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cytokeratin 19 serum fragments (CYFRA 21-1) in patients with lung cancer: results of a multicenter trial.
    Bombardieri E; Seregni E; Bogni A; Ardit S; Belloli S; Busetto A; Caniello B; Castelli M; Cianetti A; Correale M
    Int J Biol Markers; 1994; 9(2):89-95. PubMed ID: 7523547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYFRA 21-1 in lung cancer: comparison with CEA, CA 125, SCC and NSE serum levels.
    Molina R; Agusti C; Mañe JM; Filella X; Jo J; Joseph J; Giménez N; Estapé J; Ballesta AM
    Int J Biol Markers; 1994; 9(2):96-101. PubMed ID: 7523548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung cancer-associated keratin 19 fragments: development and biochemical characterisation of the new serum assay Enzymun-Test CYFRA 21-1.
    Bodenmüller H; Ofenloch-Hähnle B; Lane EB; Dessauer A; Böttger V; Donié F
    Int J Biol Markers; 1994; 9(2):75-81. PubMed ID: 7523545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra 21.1.
    van der Gaast A; Schoenmakers CH; Kok TC; Blijenberg BG; Cornillie F; Splinter TA
    Br J Cancer; 1994 Mar; 69(3):525-8. PubMed ID: 7510117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical usefulness of serum cytokeratin 19 fragment as a tumor marker for lung cancer.
    Maeda Y; Segawa Y; Takigawa N; Takata I; Fujimoto N
    Intern Med; 1996 Oct; 35(10):764-71. PubMed ID: 8933183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokeratin fragment 19 (CYFRA 21-1) as a tumor marker in non-small cell lung cancer.
    Huang MS; Jong SB; Lin MS; Chong IW; Tsai MS; Lin HC; Hwang JJ
    Kaohsiung J Med Sci; 1996 Feb; 12(2):62-8. PubMed ID: 8709175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role.
    Wieskopf B; Demangeat C; Purohit A; Stenger R; Gries P; Kreisman H; Quoix E
    Chest; 1995 Jul; 108(1):163-9. PubMed ID: 7541742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of CYFRA 21-1 as a new marker for non-small cell lung cancer.
    Niklinski J; Furman M; Chyczewska E; Chyczewski L; Rogowski F; Jaroszewicz E; Laudanski J
    Eur J Cancer Prev; 1994 Mar; 3(2):227-30. PubMed ID: 7517251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of cytokeratin 19 fragments as a marker of lung cancer by CYFRA 21-1 enzyme immunoassay.
    Takada M; Masuda N; Matsuura E; Kusunoki Y; Matui K; Nakagawa K; Yana T; Tuyuguchi I; Oohata I; Fukuoka M
    Br J Cancer; 1995 Jan; 71(1):160-5. PubMed ID: 7529525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokeratins as serum markers in lung cancer: a comparison of CYFRA 21-1 and TPS.
    Pujol JL; Grenier J; Parrat E; Lehmann M; Lafontaine T; Quantin X; Michel FB
    Am J Respir Crit Care Med; 1996 Sep; 154(3 Pt 1):725-33. PubMed ID: 8810612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of CYFRA 21-1, TPA and TPS in lung cancer, urinary bladder cancer and benign diseases.
    Stieber P; Dienemann H; Hasholzner U; Fabricius PG; Schambeck C; Weinzierl M; Poley S; Samtleben W; Hofmann K; Meier W
    Int J Biol Markers; 1994; 9(2):82-8. PubMed ID: 7523546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYFRA 21-1. A new marker in lung cancer.
    Stieber P; Hasholzner U; Bodenmüller H; Nagel D; Sunder-Plassmann L; Dienemann H; Meier W; Fateh-Moghadam A
    Cancer; 1993 Aug; 72(3):707-13. PubMed ID: 7687515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Cyfra 21-1 as a marker for lung cancer.
    Najemnik C; Mohn-Staudner A; Vetter H; Kokron O; Baumgartner G; Scheiner W; Zwick H; Koderhold G; Alth G; Dudczak R
    Wien Klin Wochenschr; 1996; 108(15):467-72. PubMed ID: 8806188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of serum CYFRA 21-1 in lung cancer.
    Muraki M; Tohda Y; Iwanaga T; Uejima H; Nagasaka Y; Nakajima S
    Cancer; 1996 Apr; 77(7):1274-7. PubMed ID: 8608502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.